362 related articles for article (PubMed ID: 32677086)
1. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor: an emerging target in central nervous system diseases.
Sperlágh B; Illes P
Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
Illes P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
[TBL] [Abstract][Full Text] [Related]
5. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
6. P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.
Freire D; Reyes RE; Baghram A; Davies DL; Asatryan L
J Neuroimmune Pharmacol; 2019 Jun; 14(2):263-277. PubMed ID: 30353422
[TBL] [Abstract][Full Text] [Related]
7. P2X7 Receptor: an Emerging Target in Alzheimer's Disease.
Huang Q; Ying J; Yu W; Dong Y; Xiong H; Zhang Y; Liu J; Wang X; Hua F
Mol Neurobiol; 2024 May; 61(5):2866-2880. PubMed ID: 37940779
[TBL] [Abstract][Full Text] [Related]
8. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists.
Soni S; Lukhey MS; Thawkar BS; Chintamaneni M; Kaur G; Joshi H; Ramniwas S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4643-4656. PubMed ID: 38349395
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
10. P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.
Gubert C; Andrejew R; Leite CE; Moritz CEJ; Scholl J; Figueiro F; Kapczinski F; da Silva Magalhães PV; Battastini AMO
Mol Neurobiol; 2020 Mar; 57(3):1347-1360. PubMed ID: 31729632
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
Antonioli L; Giron MC; Colucci R; Pellegrini C; Sacco D; Caputi V; Orso G; Tuccori M; Scarpignato C; Blandizzi C; Fornai M
PLoS One; 2014; 9(12):e116253. PubMed ID: 25549098
[TBL] [Abstract][Full Text] [Related]
12. P2X7 purinergic receptor: A potential target in heart diseases (Review).
Bin Dayel AF; Alonazi AS; Alshammari TK; Alrasheed NM
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799169
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
14. Functional P2X
Prades S; Heard G; Gale JE; Engel T; Kopp R; Nicke A; Smith KE; Jagger DJ
J Neurosci; 2021 Mar; 41(12):2615-2629. PubMed ID: 33563723
[TBL] [Abstract][Full Text] [Related]
15. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
[TBL] [Abstract][Full Text] [Related]
17. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
18. Purinergic P2X
Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
[TBL] [Abstract][Full Text] [Related]
19. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
20. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
